Epilepsy Clinical Trial
Official title:
Stress and Seizures - Can a Brief Self-help Book Help?
Background: Epilepsy and nonepileptic attack disorder (NEAD) are chronic conditions that
cause many patients to experience a great degree of stress in their everyday lives. Patients
have also reported stress as the commonest trigger of their seizures, and animal studies
suggest that stress can make seizures worse. A self-help intervention that would help people
manage the stress they experience could therefore improve their quality of life and have
positive effects on the frequency of their seizures.
Research Question: The study evaluates whether a self-help intervention in the form of a
brief booklet can improve the quality of life and reduce the levels of stress of people who
experience seizures. In addition, the study will explore the associations between seizure
severity and frequency, physiological and self-reported stress, and anxiety and depression.
Design: The researchers are recruiting patients attending the Outpatient Neurology Clinic at
the Royal Hallamshire Hospital and measure their quality of life and stress levels before,
one month and two months after they have been given the self-help stress reduction booklet.
The researchers will measure the changes in quality of life and stress levels using
questionnaires and saliva samples.
The study is a prospective randomised controlled trial. Patients are randomised to two
groups, (1) an immediate intervention group that receives the self-help intervention
immediately after recruitment, and (2) a delayed intervention group which receives the
intervention at one-month follow-up. Patients are assessed at baseline, at one-month and at
two-month follow-up.
Patients attending the neurology outpatient clinic with a confirmed diagnosis of either
epilepsy or NEAD are invited to take part in the study. The diagnosis is based on a clinical
judgement of a consultant neurologist. Information concerning the purposes and procedures of
the study is sent to patients at least 48 hours in advance of their appointment in the
neurology outpatient clinic.
Potential participants are screened for their suitability to take part in the study when
they come to the neurology clinic. This is based on the exclusion/inclusion criteria and the
patients' motivation to participate, which is assessed by five questions asking about the
relevance of stress to their lives and to their seizure experiences as well as their
interest in participating. Suitable participants have an opportunity to discuss any
questions which have arisen from reading the patients information sheet with a member of the
research team. Patients willing to take part in the project sign a consent form and complete
a set of baseline questionnaires at the time of their hospital appointment with the
neurologist, assessing their demographic characteristics, quality of life, stress levels,
anxiety, depression, seizure frequency and severity, and their tendency to self-affirm
spontaneously. As part of the baseline assessment, patients are also asked to provide two
salivary samples the following day (one at 9am in the morning, one at 10pm in the evening)
for a measure of baseline levels of salivary cortisol as a marker of physiological stress.
Patients complete a seizure diary for the duration of the study.
Patients receive treatment according to the random allocation to the immediate or delayed
intervention groups. Patients in the immediate intervention group are provided with a
booklet containing the self-help materials as soon as they have provided baseline data and
before they leave the hospital on the day of recruitment. They are encouraged to read and
work through the booklet over the following week and the researcher contacts them by
telephone one week after the baseline assessment, in order to check their progress and to
obtain feedback on the booklet, provided they had previously consented to being contacted by
telephone.
The first follow-up is arranged for both groups at one month after the initial assessment.
Subjects are contacted by post. The follow-up assessment involves completing the quality of
life, stress, anxiety, depression, and seizure severity questionnaires, submitting the
seizure diary for the past month and providing two saliva samples, one in the morning and
one in the evening. Patients in the delayed intervention group also receive the self-help
intervention booklet as part of the first follow-up assessment and are encouraged to use the
booklet in an accompanying letter. Patients in the delayed intervention group are further
contacted by telephone one week after receiving the booklet and asked to provide feedback on
their progress and on the booklet itself.
Both groups are then contacted again by letter (or telephone) for a final follow-up two
months after the initial assessment. Participants are asked to complete the quality of life,
stress, anxiety, depression, and seizure severity questionnaires, to submit their seizure
diaries and to provide two final saliva samples, one in the morning and one in the evening.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04595513 -
Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants
|
Phase 1/Phase 2 | |
Completed |
NCT02909387 -
Adapting Project UPLIFT for Blacks in Georgia
|
N/A | |
Completed |
NCT05552924 -
Self Acupressure on Fatigue and Sleep Quality in Epilepsy Patients
|
N/A | |
Terminated |
NCT01668654 -
Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS
|
Phase 3 | |
Not yet recruiting |
NCT05068323 -
Impact of Interictal Epileptiform Activity on Some Cognitive Domains in Newly Diagnosed Epileptic Patients
|
N/A | |
Completed |
NCT03994718 -
Creative Arts II Study
|
N/A | |
Recruiting |
NCT04076449 -
Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy
|
||
Completed |
NCT00782249 -
Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy
|
N/A | |
Completed |
NCT03683381 -
App-based Intervention for Treating Insomnia Among Patients With Epilepsy
|
N/A | |
Recruiting |
NCT05101161 -
Neurofeedback Using Implanted Deep Brain Stimulation Electrodes
|
N/A | |
Active, not recruiting |
NCT06034353 -
Impact of Pharmacist-led Cognitive Behavioral Intervention on Adherence and Quality of Life of Epileptic Patients
|
N/A | |
Recruiting |
NCT05769933 -
Bridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance Imaging
|
||
Not yet recruiting |
NCT06408428 -
Glioma Intraoperative MicroElectroCorticoGraphy
|
N/A | |
Not yet recruiting |
NCT05559060 -
Comorbidities of Epilepsy(Cognitive and Psychiatric Dysfunction)
|
||
Completed |
NCT02646631 -
Behavioral and Educational Tools to Improve Epilepsy Care
|
N/A | |
Completed |
NCT02977208 -
Impact of Polymorphisms of OCT2 and OCTN1 on the Kinetic Disposition of Gabapentin in Patients Undergoing Chronic Use
|
Phase 4 | |
Completed |
NCT02952456 -
Phenomenological Approach of Epilepsy in Patients With Epilepsy
|
||
Recruiting |
NCT02539134 -
TAK-935 Multiple Rising Dose Study in Healthy Participants
|
Phase 1 | |
Completed |
NCT02491073 -
Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL)
|
N/A | |
Terminated |
NCT02757547 -
Transcranial Magnetic Stimulation for Epilepsy
|
N/A |